亚洲日韩欧美综合-亚洲日韩欧美一区二区在线-亚洲日韩欧美视频-亚洲日韩精品欧美一区二区-国产欧美日韩综合

會員登錄|免費注冊|忘記密碼|管理入口 返回主站||保存桌面|手機瀏覽|聯系方式|購物車
企業會員第1年

湖北遠藥業有限公司孝南分公司  

有機原料,有機中間體,醫藥中間體,醫藥原料

搜索
新聞中心
  • 暫無新聞
產品分類
  • 暫無分類
聯系方式
  • 聯系人:顧亞男
  • 電話:027-50756114
  • 郵件:ycmanagers06@ycphar.com
  • 傳真:027-88048077-951
  • QQ:2355327070
站內搜索
 
榮譽資質
  • 暫未上傳
友情鏈接
  • 暫無鏈接
首頁 > 供應產品 > 丙基硫氧嘧啶
丙基硫氧嘧啶
單價 450.00 / KG對比
銷量 暫無
發貨 湖北武漢市付款后48小時內
庫存 6000KG起訂1KG
品牌 南箭
過期 長期有效
更新 2015-03-06 15:56
 
詳細信息
中文名稱: 丙基硫氧嘧啶
化學名稱: 4-Hydroxy-2-mercapto-6-propylpyrimidine
英文名稱:Propylthiouracil
別名:丙硫氧嘧啶
分子式:C7H10N2OS
分子量: 170.2321
CAS No:51-52-5
EINECS號:200-103-2
含量:99.0%
熔點:218-221℃
干燥失重:≤0.5%
灼燒殘渣:≤0.1%
重金屬:≤20ppm
密度:1.252g/cm3
外觀:白色結晶粉末
性質:為白色結晶或結晶性粉末。無臭,味苦。略溶于乙醇,極微溶于水。由丁?;宜嵋阴ヅc硫脲縮合而得。為抗甲狀腺藥物,可阻止甲狀腺素合成,在甲狀腺外能抑制T4轉化為T3。用于甲亢的內科治療、術前準備及甲狀腺危象的治療。制劑為片劑。注意:孕婦、哺乳期婦女慎用。與結節性甲狀腺腫合并甲亢者
包裝:25kg桶
©2025 湖北遠藥業有限公司孝南分公司 版權所有   技術支持:化工網   訪問量:23828  
 
主站蜘蛛池模板: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |